Persisting High Prevalence of Pneumococcal Carriage Among HIV-infected Adults Receiving Antiretroviral Therapy in Malawi: a Cohort Study

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2015 Jul 29

PMID 26218599

Citations 26

Authors

Ellen Heinsbroek

Terence Tafatatha

Amos Phiri

Bagrey Ngwira

Amelia C Crampin

Jonathan M Read

Neil French

Affiliations

Soon will be listed here.

Abstract

Objective: HIV-infected adults have high rates of pneumococcal carriage and invasive disease. We investigated the effect of antiretroviral therapy (ART) on pneumococcal carriage in HIV-infected adults prior to infant pneumococcal conjugate vaccine (PCV) rollout.

Design: Observational cohort study.

Methods: We recruited HIV-infected adults newly attending a rural HIV clinic in northern Malawi between 2008 and 2010. Nasopharyngeal samples were taken at baseline and after 6, 12, 18 and 24 months. We compared pneumococcal carriage by ART status using generalized estimated equation models adjusted for CD4 cell count, sex, seasonality, and other potential confounders.

Results: In total, 336 individuals were included, of which 223 individuals started ART during follow-up. Individuals receiving ART had higher pneumococcal carriage than individuals not receiving ART (25.9 vs. 19.8%, P = 0.03) particularly for serotypes not included in PCV13 (16.1 vs. 9.6% P = 0.003). Following adjustment, increased carriage of non-PCV13 serotypes was still observed for individuals on ART, but results for all serotypes were nonsignificant [all serotypes: adjusted risk ratio (aRR) 1.22 (0.95-1.56); non-PCV13 serotypes: aRR 1.72, 95% CI 1.13-2.62].

Conclusion: Pneumococcal carriage in HIV-infected adults in Malawi remained high despite use of ART, consistent with failure of mucosal immune reconstitution in the upper respiratory tract. There was evidence of increased carriage of non-PCV13 serotypes. HIV-infected adults on ART could remain an important reservoir for pneumococcal diversity post infant pneumococcal vaccine introduction. Control of pneumococcal disease in African HIV remains a priority.

Citing Articles

The relation of nasopharyngeal colonization by Streptococcus pneumoniae in comorbid adults with unfavorable outcomes in a low-middle income country.

Olivella-Gomez J, Lozada J, Serrano-Mayorga C, Mendez-Castillo L, Acosta-Gonzalez A, Vinan Garces A PLoS One. 2025; 20(2):e0318320.

PMID: 39937814 PMC: 11819510. DOI: 10.1371/journal.pone.0318320.

Estimating pneumococcal carriage dynamics in adults living with HIV in a mature infant pneumococcal conjugate vaccine programme in Malawi, a modelling study.

Phiri J, Sibale L, Mlongoti L, Mitole N, Kusakala A, Khwiya M BMC Med. 2024; 22(1):419.

PMID: 39334289 PMC: 11438070. DOI: 10.1186/s12916-024-03631-5.

Clinical and Microbial Determinants of Upper Respiratory Colonization With Streptococcus pneumoniae and Native Microbiota in People With Human Immunodeficiency Virus Type 1 and Control Adults.

Nicholson L, Kofonow J, Robertson C, Wright T, Li Q, Gardner E J Infect Dis. 2024; 230(6):1456-1465.

PMID: 38718217 PMC: 11646594. DOI: 10.1093/infdis/jiae247.

Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population.

Doherty K, Dula D, Chirwa A, Nsomba E, Nkhoma V, Toto N Wellcome Open Res. 2024; 9:2.

PMID: 38362541 PMC: 10864820. DOI: 10.12688/wellcomeopenres.19949.1.

The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi.

Obolski U, Swarthout T, Kalizangoma A, Mwalukomo T, Chan J, Weight C Nat Commun. 2023; 14(1):7477.

PMID: 37978177 PMC: 10656543. DOI: 10.1038/s41467-023-43160-y.

References

Nunes M, von Gottberg A, de Gouveia L, Cohen C, Kuwanda L, Karstaedt A . Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011; 6(11):e27929. PMC: 3225377. DOI: 10.1371/journal.pone.0027929. View

Nunes M, von Gottberg A, de Gouveia L, Cohen C, Moore D, Klugman K . The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2010; 25(4):453-62. DOI: 10.1097/QAD.0b013e328341b7f1. View

Abdullahi O, Karani A, Tigoi C, Mugo D, Kungu S, Wanjiru E . The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS One. 2012; 7(2):e30787. PMC: 3282706. DOI: 10.1371/journal.pone.0030787. View

Everett D, Mukaka M, Denis B, Gordon S, Carrol E, van Oosterhout J . Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One. 2011; 6(3):e17765. PMC: 3058053. DOI: 10.1371/journal.pone.0017765. View

OBrien K, Nohynek H . Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003; 22(2):e1-11. DOI: 10.1097/01.inf.0000049347.42983.77. View

Neill D, Fernandes V, Wisby L, Haynes A, Ferreira D, Laher A . T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog. 2012; 8(4):e1002660. PMC: 3334885. DOI: 10.1371/journal.ppat.1002660. View

Costiniuk C, Angel J . Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?. Mucosal Immunol. 2012; 5(6):596-604. DOI: 10.1038/mi.2012.82. View

Wall E, Cartwright K, Scarborough M, Ajdukiewicz K, Goodson P, Mwambene J . High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi. PLoS One. 2013; 8(7):e69783. PMC: 3716691. DOI: 10.1371/journal.pone.0069783. View

Harries A, Zachariah R, Jahn A, Schouten E, Kamoto K . Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr. 2009; 52 Suppl 1:S14-6. DOI: 10.1097/QAI.0b013e3181bbc99e. View

10.

Egere U, Townend J, Roca A, Akinsanya A, Bojang A, Nsekpong D . Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial. PLoS One. 2012; 7(11):e49143. PMC: 3504064. DOI: 10.1371/journal.pone.0049143. View

11.

Knol M, le Cessie S, Algra A, Vandenbroucke J, Groenwold R . Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ. 2011; 184(8):895-9. PMC: 3348192. DOI: 10.1503/cmaj.101715. View

12.

Gordon S, Chaponda M, Walsh A, Whitty C, Gordon M, Machili C . Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS. 2002; 16(10):1409-17. PMC: 5068550. DOI: 10.1097/00002030-200207050-00013. View

13.

Gill C, Mwanakasale V, Fox M, Chilengi R, Tembo M, Nsofwa M . Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women. J Infect Dis. 2008; 197(7):1000-5. PMC: 3869545. DOI: 10.1086/528806. View

14.

French N, Gordon S, Mwalukomo T, White S, Mwafulirwa G, Longwe H . A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med. 2010; 362(9):812-22. PMC: 2873559. DOI: 10.1056/NEJMoa0903029. View

15.

Bogaert D, de Groot R, Hermans P . Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004; 4(3):144-54. DOI: 10.1016/S1473-3099(04)00938-7. View

16.

Neill D, Coward W, Gritzfeld J, Richards L, Garcia-Garcia F, Dotor J . Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells. Am J Respir Crit Care Med. 2014; 189(10):1250-9. PMC: 4225851. DOI: 10.1164/rccm.201401-0128OC. View

17.

Jordano Q, Falco V, Almirante B, Planes A, del Valle O, Ribera E . Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004; 38(11):1623-8. DOI: 10.1086/420933. View

18.

OBrien K, Wolfson L, Watt J, Henkle E, Deloria-Knoll M, McCall N . Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374(9693):893-902. DOI: 10.1016/S0140-6736(09)61204-6. View

19.

Parrott F, Mwafulirwa C, Ngwira B, Nkhwazi S, Floyd S, Houben R . Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS One. 2011; 6(11):e27917. PMC: 3218069. DOI: 10.1371/journal.pone.0027917. View

20.

Hammitt L, Akech D, Morpeth S, Karani A, Kihuha N, Nyongesa S . Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. 2014; 2(7):e397-405. PMC: 5628631. DOI: 10.1016/S2214-109X(14)70224-4. View